Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Mast Therapeutics Logo
Mast Therapeutics CB Rank
4277220
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Acquired by
Savara Pharmaceuticals Logo
Savara Pharmaceuticals
Founded
obfuscation
DelistedPost-IPO Debt San Diego, California, United States11-50 masttherapeutics.com
Biopharma
Biotechnology
Health Care
Overview

Mast Therapeutics
Total Funding
obfuscation

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score
pts
in past quarter
Heat Score
pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Mast Therapeutics

CB Rank
4277220
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Acquired by
Savara Pharmaceuticals Logo
Savara Pharmaceuticals
Founded
obfuscation
DelistedPost-IPO Debt San Diego, California, United States11-50 masttherapeutics.com
Biopharma
Biotechnology
Health Care

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Details

Legal Name Mast Therapeutics, Inc.
Also Known As ADVENTRX Pharmaceuticals
Operating Status Closed
Stock Symbol  NYSEMKT:MSTX
Company Type For Profit
About the Company
(NYSE MKT: MSTX) We are a San Diego-based biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions.
Phone Number (858)794-4956
Contact Email info@mastthera.com
Predictions & Insights

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Mast Therapeutics Logo
Post-IPO Debt - Mast Therapeutics
1
obfuscation
— Post-IPO Debt

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1

M&A Details

Mast Therapeutics merged with Savara Pharmaceuticals on
obfuscation
.
Transaction Name 
Mast Therapeutics acquired by Savara Pharmaceuticals Logo
Mast Therapeutics acquired by Savara Pharmaceuticals
Acquired by 
Savara Pharmaceuticals Logo
Savara Pharmaceuticals
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Board Members and Advisors 1

Board Members and Advisors

News

News and Press

News•Nov 4, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 20, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 4, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 24, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Actively Used Products

5Mast Therapeutics uses 5 technology products and services including Vimeo, Adobe Flash, and  Wordpress, according to G2 Stack.

Active Website Tech Count

5Mast Therapeutics is actively using 5 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m, YouTube, and  Google Maps API.

Total IP

10The intellectual property of Mast Therapeutics includes 10 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Mast Therapeutics's headquarters? Mast Therapeutics is located in San Diego, California, United States.Who invested in Mast Therapeutics? Mast Therapeutics has 2 investors including Hercules Capital and  TCA Venture Group.When was the last funding round for Mast Therapeutics? Mast Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Debt round.How much funding has Mast Therapeutics raised to date? Mast Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|